Table 2.
Structures of the Radix Notoginseng constituents identified in FTZ preparation and serum samples from FTZ-treated rats
| Type | Substituent group | Name of constituent | MW | Observed |
|---|---|---|---|---|
|
R1=OH, R2=OGlc(2–1)Xyl, R3=OGlc | Notoginsenoside R1 | 932 | In serum and in preparation |
| R1=OH, R2=OGlc, R3=OGlc | Ginsenoside Rg1 | 800 | In serum and in preparation | |
| R1=OH, R2=OGlc(2–1)Rha, R3=OGlc | Ginsenoside Re | 946 | In preparation only | |
| R1=OH, R2=OGlc, R3=OH | Ginsenoside Rh1 | 638 | In serum and in preparation | |
| R1=OH, R2=OH, R3=OGlc | Ginsenoside F1 | 638 | In serum and in preparation | |
| R1=OGlc(2–1)Glc, R2=H, R3=OGlc(6–1)Glc | Ginsenoside Rb1 | 1108 | In serum and in preparation | |
| R1=OGlc(2–1)Glc, R2=H, R3=OGlc | Ginsenoside Rd | 946 | In serum and in preparation | |
| R1=OH, R2=OH, R3=OH | Protopanaxatriol | 476 | In serum only | |
| R1=OGlc(2–1)Glc, R2=H, R3=OH | Ginsenoside Rg3 | 784 | In serum only | |
|
R1=OGlc, R2=OH | 25-Hydroxy-ginsenoside Rh1 | 656 | In serum only |
| R1=OH, R2=OGlc | 25-Hydroxy-ginsenoside F1 | 656 | In serum only |
In serum and in preparation: the constituent was observed both in FTZ-treated serum and FTZ preparation, in preparation only: the constituent was only observed in FTZ preparation, in serum only: the constituent was only observed in FTZ-treated serum
MW molecular weight